Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Paradoxical inflammation induced by anti-TNF agents in patients with IBD.

Cleynen I, Vermeire S.

Nat Rev Gastroenterol Hepatol. 2012 Sep;9(9):496-503. doi: 10.1038/nrgastro.2012.125. Epub 2012 Jul 3. Review.

PMID:
22751454
2.

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: a report of 21 cases.

Guerra I, Algaba A, Pérez-Calle JL, Chaparro M, Marín-Jiménez I, García-Castellanos R, González-Lama Y, López-Sanromán A, Manceñido N, Martínez-Montiel P, Quintanilla E, Taxonera C, Villafruela M, Romero-Maté A, López-Serrano P, Gisbert JP, Bermejo F.

J Crohns Colitis. 2012 Jun;6(5):518-23. doi: 10.1016/j.crohns.2011.10.007. Epub 2011 Nov 13.

PMID:
22398059
3.

Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature.

Cullen G, Kroshinsky D, Cheifetz AS, Korzenik JR.

Aliment Pharmacol Ther. 2011 Dec;34(11-12):1318-27. doi: 10.1111/j.1365-2036.2011.04866.x. Epub 2011 Sep 29. Review.

4.

Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.

Magro F, Portela F.

BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. Review.

PMID:
21175228
5.

Methotrexate for psoriasiform lesions associated with anti-tumour necrosis factor therapy in inflammatory bowel disease.

Buisson A, Cuny JF, Barbaud A, Schmutz JL, Bigard MA, Guéant JL, Peyrin-Biroulet L.

Aliment Pharmacol Ther. 2012 May;35(10):1175-80. doi: 10.1111/j.1365-2036.2012.05082.x. Epub 2012 Apr 2.

6.

Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.

Fréling E, Baumann C, Cuny JF, Bigard MA, Schmutz JL, Barbaud A, Peyrin-Biroulet L.

Am J Gastroenterol. 2015 Aug;110(8):1186-96. doi: 10.1038/ajg.2015.205. Epub 2015 Jul 21.

PMID:
26195181
7.

Ustekinumab treatment of TNF antagonist-induced paradoxical psoriasis flare in a patient with psoriatic arthritis: case report and review.

Puig L, Morales-Múnera CE, López-Ferrer A, Geli C.

Dermatology. 2012;225(1):14-7. doi: 10.1159/000339864. Epub 2012 Aug 10. Review.

PMID:
22890275
8.

The association of psoriasiform rash with anti-tumor necrosis factor (anti-TNF) therapy in inflammatory bowel disease: a single academic center case series.

Afzali A, Wheat CL, Hu JK, Olerud JE, Lee SD.

J Crohns Colitis. 2014 Jun;8(6):480-8. doi: 10.1016/j.crohns.2013.10.013. Epub 2013 Nov 21.

PMID:
24268978
9.

Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study.

Fouache D, Goëb V, Massy-Guillemant N, Avenel G, Bacquet-Deschryver H, Kozyreff-Meurice M, Ménard JF, Muraine M, Savoye G, Le Loët X, Tharasse C, Vittecoq O.

Rheumatology (Oxford). 2009 Jul;48(7):761-4. doi: 10.1093/rheumatology/kep083. Epub 2009 Apr 24.

10.

Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents.

Fiorino G, Danese S, Pariente B, Allez M.

Autoimmun Rev. 2014 Jan;13(1):15-9. doi: 10.1016/j.autrev.2013.06.005. Epub 2013 Jun 15. Review.

PMID:
23777821
11.

TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases.

Wiedmann MW, Mössner J, Baerwald C, Pierer M.

Endocr Metab Immune Disord Drug Targets. 2009 Sep;9(3):295-314. Epub 2009 Sep 1. Review.

PMID:
19594416
12.

The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.

Sfikakis PP.

Curr Dir Autoimmun. 2010;11:180-210. doi: 10.1159/000289205. Epub 2010 Feb 18. Review.

PMID:
20173395
13.

Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues.

Caviglia R, Boskoski I, Cicala M.

Expert Opin Drug Saf. 2008 Sep;7(5):617-32. doi: 10.1517/14740338.7.5.617 . Review.

PMID:
18759714
14.

Management of psoriatic lesions associated with anti-TNF therapy in patients with IBD.

Denadai R, Teixeira FV, Saad-Hossne R.

Nat Rev Gastroenterol Hepatol. 2012 Dec;9(12):744. doi: 10.1038/nrgastro.2012.125-c1. Epub 2012 Nov 13. No abstract available.

PMID:
23147656
15.

Risks of serious infection or lymphoma with anti-tumor necrosis factor therapy for pediatric inflammatory bowel disease: a systematic review.

Dulai PS, Thompson KD, Blunt HB, Dubinsky MC, Siegel CA.

Clin Gastroenterol Hepatol. 2014 Sep;12(9):1443-51; quiz e88-9. doi: 10.1016/j.cgh.2014.01.021. Epub 2014 Jan 22. Review.

PMID:
24462626
16.

Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?

Kilic O, Kasapcopur O, Camcioglu Y, Cokugras H, Arisoy N, Akcakaya N.

Rheumatol Int. 2012 Sep;32(9):2675-9. doi: 10.1007/s00296-011-2030-8. Epub 2011 Jul 26.

PMID:
21789614
17.

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents.

Braun J, Baraliakos X, Listing J, Davis J, van der Heijde D, Haibel H, Rudwaleit M, Sieper J.

Arthritis Rheum. 2007 May 15;57(4):639-47. Review.

18.

Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children.

Perman MJ, Lovell DJ, Denson LA, Farrell MK, Lucky AW.

Pediatr Dermatol. 2012 Jul-Aug;29(4):454-9. doi: 10.1111/j.1525-1470.2011.01521.x. Epub 2011 Oct 13.

PMID:
21995665
19.

Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis.

Collamer AN, Battafarano DF.

Semin Arthritis Rheum. 2010 Dec;40(3):233-40. doi: 10.1016/j.semarthrit.2010.04.003. Epub 2010 Jun 26. Review.

PMID:
20580412
20.

[Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].

Sansó Sureda A, Rocamora Durán V, Sapiña Camaró A, Royo Escosa V, Bosque López MJ.

Gastroenterol Hepatol. 2011 Oct;34(8):546-50. doi: 10.1016/j.gastrohep.2011.04.003. Epub 2011 Jun 12. Spanish.

PMID:
21665330
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk